Regulation

NMPA’s Attitude Towards Joint R&D between Cosmetic Companies and Medical Institutions via Chemlinked

NMPA’s attitude can be summarized in two aspects:

1. NMPA encourages companies to further strengthen cooperation with scientific research institutes, and indeed improve cosmetic R&D capability;

2. Meanwhile, NMPA firmly opposes companies using “medical innovation” as a gimmick to promote cosmetics. Companies should not use medical terms when promoting cosmetics, so as not to mislead consumers that products have medical efficacies.

“Cosmetics are closely related to dermatology. We encourage the cooperation among companies, hospitals, and scientific research institutes to develop more competitive cosmetics for consumers to solve skin problems,” During the panel discussion, Qi said.

 

Read more…

 

Recent Posts

Roger Guillemin: Neuroscientist who Showed How the Brain Controls Hormones via Nature

Roger Guillemin identified the molecules in the brain that control the production of hormones in…

Mitigating Multi-Source Hair Damage via Cosmetics and Toiletries

In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…

“If things go in the Wrong Direction, it Could be a Significant Challenge to the Industry”: Cosmetics Europe director on EU Regulations

We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…